ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2018 American Transplant Congress

    The Role of pDCs in Formation of Treg-Rich Organized Lymphoid Structures in Spontaneously Accepted Murine Kidney Allografts is Dependent on Mismatching of MHC Class II Molecules at the H2-I-Ab Locus

    T. O'Shea,1,2 C. Yang,1 I. Rosales,2 N. Oh,1 D. Ndishibandi,1,2 T. Ashry,1 P. Russell,1 J. Madsen,1 R. Colvin,2 A. Alessandrini.1,2

    1Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA; 2Department of Pathology, Massachusetts General Hospital, Boston, MA.

    Introduction: Our lab has demonstrated that murine kidney allografts are spontaneously accepted in specific donor-recipient strain combinations. Histologic examination of spontaneously accepted DBA/2J (DBA) kidneys…
  • 2018 American Transplant Congress

    The Brazilian Epitope Virtual Crossmatch Protocol: A Reliable Tool for Increasing Kidney Allocation among Highly Sensitized Patients

    L. Sousa,1 A. Silva,1 M. Marroquim,1 A. Coelho,1 A. Lima,1 F. Silva,1 C. Carracosa,2 G. Willcox,3 T. Leão,3 B. Correa,3 E. Guimarães,3 G. Maciel,3 J. Andrade,4 A. Andrade,4 R. Neto,4 S. Cavalcante,4 C. Leão,4 F. Cavalcante,5 A. Holanda,5 N. Gomes,6 A. Rego,6 S. Monte.1

    1UFPI, Teresina, PI, Brazil; 2PUC, Curitiba, PR, Brazil; 3HLA Diagnostico, Recife, PE, Brazil; 4IMIP, Recife, PE, Brazil; 5RHP, Recife, PE, Brazil; 6CNCDO, Recife, PE, Brazil.

    Background: In Brazil (BZ), the kidney allocation policy for highly sensitized patients (HS) (PRA ≥ 80%) does not involve prioritization and transplants 10 times less…
  • 2018 American Transplant Congress

    Many Highly Sensitized Candidates Still Waiting for Transplant Despite the Kidney Allocation System Change: Making the Case for Incompatible Transplantation

    C. Schinstock, B. Smith, A. Bentall, M. Stegall.

    Von Liebig Center for Transplantation and Clinical Regenerative Medicine, Mayo Clinic, Rochester, MN.

    Introduction: The rate of kidney transplantation in highly sensitized individuals has increased since the kidney allocation system (KAS) change, but it remains unclear who has…
  • 2018 American Transplant Congress

    Effect of rATG on Monocytic Myeloid-Derived Suppressor Cells and Its Associated Mechanisms in Kidney Transplantation Recipients

    Y. Jiang, X. Zhang.

    Beijing Chao-Yang Hospital, Beijing, China.

    Myeloid-derived suppressor cells (MDSCs) consist of heterogeneous myeloid progenitors and precursors that was first defined in cancer patients and are characterized by a regulatory ability…
  • 2018 American Transplant Congress

    Thymoglobulin Dose and Effect on Short-Term Kidney Transplant Outcomes

    P. Sood, W. Christine, R. Mehta, A. Tevar, C. Puttarajappa, K. Schonder, K. Shimko, S. Hariharan.

    University of Pitstburgh Medical Center, Pittsburgh.

    Thymoglobulin is a commonly used induction agent for kidney transplantation. Optimal dosing for thymoglobulin is not well defined, and weight based dosing is often used.…
  • 2018 American Transplant Congress

    Graft Failure in Recurrent IgA Nephropathy Following Living Kidney Transplantation: Predictive Factors Analysis of 102 Biopsies

    J. Zhang, J. Qiu, G. Chen, C. Wang, L. Chen.

    Organ Transplant Unit, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

    Aim To investigate the predictive factors related to graft failure in recurrentIgA nephropathy (IgAN) following living kidney transplantation. Methods We identified a series of 102…
  • 2018 American Transplant Congress

    The Incidence and Risk Factors for Non – Adherence to Medical Treatment among Patients after Kidney Transplantation

    T. Mashraki,1,2,3 B. Rozen-Zvi,1,4 E. Mor,2,4 A. Yussim,1,2 C. Avry,1,4 R. Rahamimov.1,2,3

    1Nephrology and Hypertension, Rabin Medical Center, Petach Tikva, Israel; 2Transplantation, Rabin Medical Center, Petach Tikva, Israel; 3Faculty of Health Science, Ariel University Center of Samaria, Ariel, Israel; 4Sackler Faculty of Medicine, Tel- Aviv University, Tel- Aviv, Israel.

    Background: Nonadherence to medical treatment is an important risk factor for acute rejection and graft loss. In this study we sought to determine the prevalence…
  • 2018 American Transplant Congress

    Transplantation of Very Small Pediatric En Bloc Renal Allografts from Donors Less Than 8 Months of Age Have Similar Outcomes to Donors More Than 8 Months

    S. Aquil,1,2,3 N. Mitrou,1,3 V. McAlister,1,2,3 A. Sener,1,2,3 P. Luke.1,2,3

    1Departments of Surgery and Transplant, London Health Sciences Centre, University Hospital, London, ON, Canada; 2Microbiology and Immunology and Matthew Mailing Center for Transplant Studies, London Health Sciences Centre, University Hospital, London, ON, Canada; 3Departments of Surgery and Transplant, Western University, London, ON, Canada.

    Purpose: Few programs use kidneys from donors with body weight (BW) less than 10 kg or less than 8 months of age, for fear of…
  • 2018 American Transplant Congress

    A Review of Pediatric Drug Development Programs and FDA Labeling for Immunosuppressive Drugs in Organ Transplant Patients

    G. Burckart,1 M. Cavaillé-Coll,2 A. Duong,3 L. Hothem,4 R. Albrecht.2

    1Office of Clinical Pharmacology, Office of Translational Science, CDER, US Food and Drug Administration, Silver Spring, MD; 2Division of Transplant and Opthalmology Products, Office of New Drugs, CDER, US Food and Drug Administration, Silver Spring, MD; 3Tauro University, New York, NY; 4University of North Carolina, Chapel Hill, NC.

    The development of drugs for organ transplantation spanned the time before and after pediatric regulatory requirements under the Best Pharmaceuticals for Children Act (BPCA) and…
  • 2018 American Transplant Congress

    Tumor Recurrence in Kidney Transplant Recipients with a History of Pretransplant Malignancy

    F. Becker,1 K. Schütte Nütgen,2 S. Reuter,2 L. Kebschull,1 T. Vowinkel,1 N. Senninger,1 D. Palmes,1 T. Vogel,1 R. Bahde.1

    1Department for General and Visceral Surgery, University Hospital Münster, Münster, Germany; 2Department of Internal Medicine D, University Hospital Münster, Münster, Germany.

    Introduction: A growing body of evidence indicates that kidney transplant recipients (KTR) with a history of pre-transplant malignancy (PTM)have a higher incidence of post-transplant de-novo…
  • « Previous Page
  • 1
  • …
  • 328
  • 329
  • 330
  • 331
  • 332
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences